描述慢性进口杆菌病的治疗后的血清反应
Marta González-Sanz1,2, Irene Martín-Rubio1, Oihane Martín3,4
1National Reference Centre for Imported Tropical Diseases, Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.
Tropical medicine and infectious disease
|January 24, 2025
概括
血清学测试显示,施索米亚症在治疗后显著下降,有助于监测慢性病例. 需要进一步的研究来优化后续时间,并确定负面结果的因素.
科学领域:
- 传染性疾病 传染性疾病
- 热带医学 热带医学
- 寄生虫学的寄生虫学
背景情况:
- 慢性杆菌病导致显著的发病率,血清学在治疗反应评估中的作用正在争论中.
- 进口的石杆菌病例在非流行地区带来了独特的挑战.
研究的目的:
- 在治疗慢性进口杆菌病后分析血清学值.
- 评估血清学标记在监测治疗反应中的有用性.
主要方法:
- 对为慢性进口杆菌病 (2018-2022) 治疗的患者进行了回顾性观察研究.
- 对人口,临床和实验室数据的分析,包括基线和随访血清学.
- 用于评估血清学价值演变的通用估计方程 (GEE) 模型和卡普兰-梅尔曲线.
主要成果:
- 包括83名患者;大多数是来自撒哈拉以南非洲的男性移民.
- 在大多数患者中,初始阳性静脉瘤ELISA和IHA血清学.
- 治疗后ELISA和IHA值显著下降; 25%的患者在63周后获得了负ELISA.
结论:
- 连续的血清学测定可以帮助监测非流行地区的慢性杆菌病.
- 随访血清学测试的最佳时间需要进一步调查.
- 需要进行研究,以确定影响治疗后阴性血清学结果的因素.
相关概念视频
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


